IL6 and breast cancer: Similarly, Kim and colleagues showed that knockdown of tumor suppressor Pten and Tp53 in breast cancer cells synergized to activate a pro-inflammatory Il-6/Stat3/NF-κB signaling axis (Kim et al., 2015).